BACKGROUND: The scheduled update to the German S3 guidelines on fibromyalgia syndrome (FMS) by the Association of the Scientific Medical Societies ("Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften", AWMF; registration number 041/004) was planned starting in March 2011. MATERIALS AND METHODS: The development of the guidelines was coordinated by the German Interdisciplinary Association for Pain Therapy ("Deutsche Interdisziplinären Vereinigung für Schmerztherapie", DIVS), 9 scientific medical societies and 2 patient self-help organizations. Eight working groups with a total of 50 members were evenly balanced in terms of gender, medical field, potential conflicts of interest and hierarchical position in the medical and scientific fields. Literature searches were performed using the Medline, PsycInfo, Scopus and Cochrane Library databases (until December 2010). The grading of the strength of the evidence followed the scheme of the Oxford Centre for Evidence-Based Medicine. The formulation and grading of recommendations was accomplished using a multi-step, formal consensus process. The guidelines were reviewed by the boards of the participating scientific medical societies. RESULTS AND CONCLUSION: The use of a multicomponent therapy (the combination of aerobic exercise with at least one psychological therapy) for a minimum of 24 h is strongly recommended for patients with severe FMS. The English full-text version of this article is available at SpringerLink (under "Supplemental").
BACKGROUND: The scheduled update to the German S3 guidelines on fibromyalgia syndrome (FMS) by the Association of the Scientific Medical Societies ("Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften", AWMF; registration number 041/004) was planned starting in March 2011. MATERIALS AND METHODS: The development of the guidelines was coordinated by the German Interdisciplinary Association for Pain Therapy ("Deutsche Interdisziplinären Vereinigung für Schmerztherapie", DIVS), 9 scientific medical societies and 2 patient self-help organizations. Eight working groups with a total of 50 members were evenly balanced in terms of gender, medical field, potential conflicts of interest and hierarchical position in the medical and scientific fields. Literature searches were performed using the Medline, PsycInfo, Scopus and Cochrane Library databases (until December 2010). The grading of the strength of the evidence followed the scheme of the Oxford Centre for Evidence-Based Medicine. The formulation and grading of recommendations was accomplished using a multi-step, formal consensus process. The guidelines were reviewed by the boards of the participating scientific medical societies. RESULTS AND CONCLUSION: The use of a multicomponent therapy (the combination of aerobic exercise with at least one psychological therapy) for a minimum of 24 h is strongly recommended for patients with severe FMS. The English full-text version of this article is available at SpringerLink (under "Supplemental").
Authors: Saskia van Koulil; Wim van Lankveld; Floris W Kraaimaat; Toon van Helmond; Annemieke Vedder; Hanneke van Hoorn; Rogier Donders; Alphons J L de Jong; Joost F Haverman; Kurt-Jan Korff; Piet L C M van Riel; Hans A Cats; Andrea W M Evers Journal: Arthritis Care Res (Hoboken) Date: 2010-10 Impact factor: 4.794
Authors: Daniel S Rooks; Shiva Gautam; Matthew Romeling; Martha L Cross; Diana Stratigakis; Brittany Evans; Don L Goldenberg; Maura D Iversen; Jeffrey N Katz Journal: Arch Intern Med Date: 2007-11-12
Authors: C Cedraschi; J Desmeules; E Rapiti; E Baumgartner; P Cohen; A Finckh; A F Allaz; T L Vischer Journal: Ann Rheum Dis Date: 2004-03 Impact factor: 19.103
Authors: B Arnold; W Häuser; K Bernardy; W Brückle; E Friedel; V Köllner; H Kühn-Becker; M Richter; M Weigl; T Weiss; M Offenbächer Journal: Schmerz Date: 2008-06 Impact factor: 1.107
Authors: Rosa Alves Targino; Marta Imamura; Helena H S Kaziyama; Luiz P M Souza; Wu Tu Hsing; Andréa D Furlan; Satiko Tomikawa Imamura; Raymundo Soares Azevedo Neto Journal: J Rehabil Med Date: 2008-07 Impact factor: 2.912
Authors: M Schiltenwolf; U Eidmann; V Köllner; T Kühn; M Offenbächer; F Petzke; M Sarholz; M Weigl; B Wolf; W Häuser Journal: Schmerz Date: 2017-06 Impact factor: 1.107
Authors: W Eich; W Häuser; B Arnold; K Bernardy; W Brückle; U Eidmann; K Klimczyk; V Köllner; H Kühn-Becker; M Offenbächer; M Settan; M von Wachter; F Petzke Journal: Schmerz Date: 2012-06 Impact factor: 1.107
Authors: Ali Osman Bağdatlı; Arif Donmez; Rıza Eröksüz; Güler Bahadır; Mustafa Turan; Nergis Erdoğan Journal: Int J Biometeorol Date: 2015-04-28 Impact factor: 3.787
Authors: Joanna Leaviss; Sarah Davis; Shijie Ren; Jean Hamilton; Alison Scope; Andrew Booth; Anthea Sutton; Glenys Parry; Marta Buszewicz; Rona Moss-Morris; Peter White Journal: Health Technol Assess Date: 2020-09 Impact factor: 4.014